文献速递流行病学与生物统计真实世界研究与卫生经济

将临床试验数据与电子健康记录整合以提高研究多样性:一家城市医院系统的发现

Integrating clinical trial data with electronic health records to improve diversity in research: findings from an urban hospital system.
PubMed 文献 · Trials · 2026-01-26

该质量改进项目分析了2017至2024年城市医院系统内1767名药物或器械临床试验成年参与者的种族和民族分布,并与患者总体和当地人口普查数据比较。参与者中白人占83.1%,高于患者总体的73.1%,黑人和女性参与者比例从2017至2024年上升。研究旨在为ARISE项目设定入组目标和招募指标提供依据。

要点

  • 临床试验参与者较患者总体更可能为55-74岁年长组和白人(83.1% vs 73.1%)。
  • 与当地人口普查比较,参与者年长组更多,白人增加而黑人减少。
  • 2017至2024年黑人和女性参与者比例上升,白人参与下降,西班牙裔参与比例波动但低于普查和患者总体水平。

核心结论

  • 研究结果将直接为ARISE项目未来策略提供信息,用于设定入组目标和创建招募指标,以促进临床试验中种族和民族少数群体及其他健康差异人群的代表性。
  • 未来研究应整合原始和次要数据,将临床试验的入选标准作为额外基准比较,以推断多样性和代表性。

研究设计与样本

  • 本研究采用连续独立样本设计,描述2017至2024年入组药物或器械临床试验的1767名成年研究参与者的人口学分布。
  • 人口学数据整合自电子健康记录,并总体和按年份汇总。
  • 使用独立比例z检验将研究参与者人口学与患者总体(N=2,062,865)和当地人口普查(N=608,210)比较。
  • 使用Cohen's h计算效应量估计,以确定研究参与者、患者总体和当地人口普查之间实际显著的差异。

主要发现

  • 研究参与者较患者总体更可能代表55-74岁年长组(原文未报告具体比例)和白人种族(83.1% vs 73.1%),但在民族和生理性别方面相当。
  • 与当地人口普查数据比较,研究参与者更可能代表年长组,同时观察到白人参与者增加和黑人参与者减少。
  • 2017至2024年黑人和女性参与者比例上升,而白人参与下降。
  • 2017至2024年西班牙裔研究参与比例波动,但保持在人口普查和患者总体水平以下(分别为4.7%和5.3%)。

局限性

  • 未来研究应整合原始和次要数据,将临床试验的入选标准作为额外基准比较,以推断多样性和代表性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Underrepresentation of racial and ethnic minorities, women, and certain age groups in clinical trials continues to threaten the validity of novel therapeutic interventions and exacerbate longstanding inequities in health outcomes. Despite attention and mandates across institutions and federal agencies to address these disparities, effective and actionable strategies have remained a subject of debate in the existing literature. This study provides preliminary findings from the Advancing Research Through Inclusivity, Sustainability, and Equity (ARISE) Program, a quality improvement initiative to improve representation of racial and ethnic minorities and other underrepresented populations (e.g., women, certain age groups) in clinical trials conducted in an urban hospital system. The primary objective of this study was to examine the racial and ethnic distribution of research participants enrolled in drug and device clinical trials from 2017 to 2024. The secondary objective was to integrate electronic health records and local census data to create benchmarks for comparative purposes. METHODS: This study employed a successive-independent samples design to characterize the demographic distribution of 1767 adult research participants enrolled in a drug or device clinical trial from 2017 to 2024. Demographic data were integrated from electronic health records and summarized overall and by year. The z-test for independent proportions was used to compare the research participant demographics to the overall patient population (N = 2,062,865) and local census (N = 608,210). Effect size estimates were calculated using Cohen's h to determine practically significant differences between research participants, the overall patient population, and local census. RESULTS: Research participants were more likely than the patient population to represent older age groups (55-74 years) and White race (83.1% vs 73.1%) but were comparable in terms of ethnicity and biological sex. When compared to local census data, research participants were more likely to represent older age groups, while increases in White participants and decreases in Black participants were observed. There were increases in the proportions of Black and female participants from 2017 to 2024, while White participation decreased. The proportion of Hispanic research participation fluctuated from 2017 to 2024 but remained below census and patient population levels (4.7% and 5.3%, respectively). CONCLUSIONS: The findings from this study will directly inform future strategies of the ARISE Program for setting enrollment goals and creating recruitment metrics that facilitate increased representation of racial and ethnic minorities and other health disparity populations in clinical trials. Future studies should integrate primary and secondary data to take into consideration the eligibility criteria from clinical trials as an additional benchmark comparison when making inferences about diversity and representation.

来源:Trials,查看原文。版权归原作者所有。

引用

  1. Brown EH, Peiper NC, Furmanek S, et al. Integrating clinical trial data with electronic health records to improve diversity in research: findings from an urban hospital system. Trials. 2026. PMID: 41582222. doi:10.1186/s13063-026-09492-y

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。